MiMedx Group, Inc. (MDXG) vs Olema Pharmaceuticals, Inc. (OLMA)
A side-by-side comparison of MiMedx Group, Inc. and Olema Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDXG
MiMedx Group, Inc.
$4.59HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
OLMA
Olema Pharmaceuticals, Inc.
$8.10HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — MDXG vs OLMA
growth of $100 · dividends reinvested · last 6yMDXG -31.7% (-6.2%/yr)OLMA -83.2% (-25.7%/yr)MDXG compounded faster over this window
MDXG OLMA
MDXG vs OLMA: by the numbers
- •OLMA is the larger company ($707M vs $669M market cap).
- •MDXG is profitable (1.76% net margin) while OLMA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | MDXG | OLMA |
|---|---|---|
| P/E ratio | 114.66 | N/A |
| P/S ratio | 1.88 | N/A |
| P/B ratio | 3.10 | 1.64 |
| EV / EBITDA | 26.17 | N/A |
| FCF yield | 6.07% | N/A |
Profitability
| Metric | MDXG | OLMA |
|---|---|---|
| Gross margin | 78.85% | 0.00% |
| Operating margin | 15.26% | 0.00% |
| Net margin | 1.76% | 0.00% |
| ROE | 2.89% | -47.51% |
| ROIC | 1.97% | -50.92% |
Growth (annualized)
| Metric | MDXG | OLMA |
|---|---|---|
| Revenue CAGR (5Y) | 6.36% | N/A |
| Total return CAGR (5Y) | -4.94% | -21.50% |
Frequently asked
- Is MDXG or OLMA more profitable?
- MDXG runs the higher net margin — MDXG at 1.76% versus OLMA at 0.00%.
- How have MDXG and OLMA total returns compared?
- Over the past 5 years, MDXG delivered -4.94% and OLMA delivered -21.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
MiMedx P/E ratioMiMedx ROEOlema Pharmaceuticals ROEMiMedx operating marginOlema Pharmaceuticals operating marginMiMedx revenue growthOlema Pharmaceuticals revenue growthMiMedx free cash flowOlema Pharmaceuticals free cash flow
MiMedx & Olema Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.